Testing a wearable glucose sensor to help people with glioblastoma manage blood sugar
Original title: Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This study does not list a phase, so we treat it as an early test in people.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This trial is testing whether a small sensor that tracks blood sugar can help people with a brain tumor called glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary.
Who this trial is for. This trial is for people with glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary, the most common malignant primary brain tumor in adults. It is testing continuous glucose monitoring, called CGM, which uses a sensor placed under the skin to check blood sugar levels again and again through the day.
Where it stands. The trial has not reported results. It is looking at whether CGM helps patients manage high blood sugar and whether it improves survival. High blood sugar during radiation therapy has been linked to poorer survival in glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary, and steroids given during treatment often push blood sugar up. Whether CGM changes that is the question this trial is asking. The answer is not in yet.
What this means, and what it doesn't
What it could mean: If CGM works as hoped, it could show changes in blood sugar sooner. That could mean treatment or medicine is given sooner. Someone with glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary who is having trouble with high blood sugar could ask their care team about this trial.
What it doesn't mean: This does not mean CGM is a proven treatment for glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary. A trial is a test. We do not yet know if it helps. Joining a trial is not a guarantee that you will benefit. This is not a promise of a cure. Whether anyone can join is decided by the trial team.
Source: ClinicalTrials.gov, August 4, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.